Compare LENZ & AXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LENZ | AXR |
|---|---|---|
| Founded | 2019 | 1961 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Homebuilding |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 155.5M | 132.0M |
| IPO Year | 2021 | 2010 |
| Metric | LENZ | AXR |
|---|---|---|
| Price | $4.58 | $23.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $44.00 | $30.00 |
| AVG Volume (30 Days) | ★ 817.7K | 12.3K |
| Earning Date | 05-06-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.91 |
| Revenue | ★ $19,088,000.00 | $12,831,000.00 |
| Revenue This Year | $50.42 | $10.12 |
| Revenue Next Year | $197.16 | N/A |
| P/E Ratio | ★ N/A | $12.17 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.54 | $17.61 |
| 52 Week High | $50.19 | $29.01 |
| Indicator | LENZ | AXR |
|---|---|---|
| Relative Strength Index (RSI) | 36.98 | 50.15 |
| Support Level | N/A | $23.02 |
| Resistance Level | $6.18 | $23.52 |
| Average True Range (ATR) | 0.41 | 0.61 |
| MACD | -0.02 | 0.19 |
| Stochastic Oscillator | 2.49 | 96.85 |
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.
Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve obtaining approvals and selling both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. The Company accounts for land sales, home sales, and other revenues. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.